Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Giugliani

Showing results (91-100 of 482) with videos related to

Pageof 49
Sort By:
The Lancet. Child & Adolescent Health|September 1, 2018
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNSRoberto Giugliani, Filippo Vairo, Francyne Kubaski, et al.
Journal of Neuromuscular Diseases|November 19, 2016
A Case of Early Infantile Pompe Disease with Atypical ManifestationCarolina F M de Souza, Karina Donnis, Filippo Vairo, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 13, 2009
Urinary oligosaccharides: a peripheral marker for Sida carpinifolia exposure or poisoningMarisete Bedin, Edson M Colodel, Roberto Giugliani, et al.
Journal of Inherited Metabolic Disease|September 18, 2012
Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficitsGuilherme Baldo, David F Wozniak, Kevin K Ohlemiller, et al.
Journal of Inherited Metabolic Disease|February 5, 2017
Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis IEsteban Alberto Gonzalez, Angela Maria Vicente Tavares, Edina Poletto, et al.
Current Pharmaceutical Design|November 3, 2020
Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease)Francyne Kubaski, Filippo Vairo, Guilherme Baldo, et al.
Molecular Genetics and Metabolism|December 19, 2008
New GLB1 mutation in siblings with Morquio type B disease presenting with mental regressionFabiana Quoos Mayer, Fernanda dos Santos Pereira, Anthony H Fensom, et al.
Molecular Genetics and Metabolism|August 15, 2020
Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trialChristine Í Dali, Caroline Sevin, Ingeborg Krägeloh-Mann, et al.
Asian Pacific Journal of Tropical Biomedicine|April 10, 2013
Glucose-6-phosphate-dehydrogenase deficiency and its correlation with other risk factors in jaundiced newborns in Southern BrazilClarissa Gutiérrez Carvalho, Simone Martins Castro, Ana Paula Santin, et al.
Plos One|February 4, 2015
Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type IGabriela Pasqualim, Guilherme Baldo, Talita Giacomet de Carvalho, et al.
Pageof 49

Showing results (91-100 of 482) with videos related to

Sort By:
Pageof 49
The Lancet. Child & Adolescent Health|September 1, 2018
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNSRoberto Giugliani, Filippo Vairo, Francyne Kubaski, et al.
Journal of Neuromuscular Diseases|November 19, 2016
A Case of Early Infantile Pompe Disease with Atypical ManifestationCarolina F M de Souza, Karina Donnis, Filippo Vairo, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 13, 2009
Urinary oligosaccharides: a peripheral marker for Sida carpinifolia exposure or poisoningMarisete Bedin, Edson M Colodel, Roberto Giugliani, et al.
Journal of Inherited Metabolic Disease|September 18, 2012
Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficitsGuilherme Baldo, David F Wozniak, Kevin K Ohlemiller, et al.
Journal of Inherited Metabolic Disease|February 5, 2017
Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis IEsteban Alberto Gonzalez, Angela Maria Vicente Tavares, Edina Poletto, et al.
Current Pharmaceutical Design|November 3, 2020
Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease)Francyne Kubaski, Filippo Vairo, Guilherme Baldo, et al.
Molecular Genetics and Metabolism|December 19, 2008
New GLB1 mutation in siblings with Morquio type B disease presenting with mental regressionFabiana Quoos Mayer, Fernanda dos Santos Pereira, Anthony H Fensom, et al.
Molecular Genetics and Metabolism|August 15, 2020
Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trialChristine Í Dali, Caroline Sevin, Ingeborg Krägeloh-Mann, et al.
Asian Pacific Journal of Tropical Biomedicine|April 10, 2013
Glucose-6-phosphate-dehydrogenase deficiency and its correlation with other risk factors in jaundiced newborns in Southern BrazilClarissa Gutiérrez Carvalho, Simone Martins Castro, Ana Paula Santin, et al.
Plos One|February 4, 2015
Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type IGabriela Pasqualim, Guilherme Baldo, Talita Giacomet de Carvalho, et al.
Pageof 49